| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.026 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.012 | 0.9 |